Notes From Underground: Miners Face Increased Risk of Rheumatoid Arthritis
(MedPage Today) -- Add "hard rock" mining to the list of occupations associated with high rates of rheumatoid arthritis (RA), a new study indicated, with silica exposure the presumed malefactor. Based on survey data from men ages 50 and older... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - October 17, 2022 Category: American Health Source Type: news

Should You Stay or Go? When to Change Treatments
Advice from rheumatologists for changing psoriatic arthritis medications, including side effects, symptoms, and insurance coverage. (Source: WebMD Health)
Source: WebMD Health - October 14, 2022 Category: Consumer Health News Source Type: news

Turmeric may help reduce arthritis pain – 'More effective than placebo for knee pain'
Arthritis is a chronic condition which can cause pain in every area of the body, but sometimes changes in diet could relieve the symptoms. (Source: Daily Express - Health)
Source: Daily Express - Health - October 14, 2022 Category: Consumer Health News Source Type: news

Study: Patient Reports Can Substitute for Objective Measures in RA Evaluation
(MedPage Today) -- A model incorporating rheumatoid arthritis (RA) patients' self-reports matched conventional physician-led evaluations of disease activity to an acceptable degree, researchers said. "Machine learning" applied to data collected... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - October 13, 2022 Category: Rheumatology Source Type: news

MTX to Increase Response in Gout Receiving Pegloticase MTX to Increase Response in Gout Receiving Pegloticase
Might the addition of methotrexate help increase pegloticase treatment response in patients with uncontrolled gout?Arthritis Research & Therapy (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 11, 2022 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Vegetables could help alleviate symptoms of arthritis - but which ones are best?
Arthritis can cause painful symptoms for many, and diet can play a key role in alleviating symptoms. (Source: Daily Express - Health)
Source: Daily Express - Health - October 11, 2022 Category: Consumer Health News Source Type: news

Mayo Clinic expert offers tips on how to keep joints healthy as you age
World Arthritis Day is Oct. 12 ROCHESTER, Minn. — For joints to work well, they need cartilage, a slippery tissue that covers the ends of bones, acts like a shock absorber, and helps joints move smoothly. Joaquin Sanchez-Sotelo, M.D., Ph.D., a Mayo Clinic orthopedic surgeon, says many people lose cartilage as they age, but it does not mean that joint replacement is inevitable. Here are some tips for keeping joints healthy. Cartilage degenerates for various… (Source: Mayo Clinic Minnesota News)
Source: Mayo Clinic Minnesota News - October 11, 2022 Category: Hospital Management Source Type: news

PsA Guidelines Need Improvement on Conflicts of Interest PsA Guidelines Need Improvement on Conflicts of Interest
Many authors of psoriatic arthritis guidelines from the American College of Rheumatology and the Japanese Dermatological Society have undisclosed financial conflicts of interest.MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - October 10, 2022 Category: Dermatology Tags: Rheumatology News Source Type: news

Why Some Psoriatic Disease Symptoms Are Unreported
Why do symptoms of psoriasis, psoriatic arthritis, and psoriatic disease get missed? Find out from a psoriatic disease advocate. (Source: WebMD Health)
Source: WebMD Health - October 10, 2022 Category: Consumer Health News Source Type: news

STELARA ® (ustekinumab) Demonstrated Sustained Symptomatic and Corticosteroid-Free Remission Through Four Years in Adults with Moderately to Severely Active Ulcerative Colitis
SPRING HOUSE, PENNSYLVANIA, October 10, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced final data from the long-term extension (LTE) of the Phase 3 UNIFI study demonstrating efficacy and safety of STELARA® (ustekinumab) through four years of treatment in adult patients with moderately to severely active ulcerative colitis (UC).1 Among all patients who had achieved clinical responsea with STELARA during induction, 64.9 percent were in symptomatic remissionb after 44 weeks of maintenance. At week 200 (four years), this proportion of patients was 55.2 percent; the majority (96.4 percen...
Source: Johnson and Johnson - October 10, 2022 Category: Pharmaceuticals Source Type: news

Results of Novel Clinical Study of Guselkumab and Golimumab Combination Therapy Show Adults with Moderately to Severely Active Ulcerative Colitis Maintained Higher Rates of Clinical, Histologic, and Endoscopic Remission at Week 38
SPRING HOUSE, PENNSYLVANIA, October 10, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from an ongoing analysis of a Phase 2a clinical trial showing adults with moderately to severely active ulcerative colitis (UC) who received 12 weeks of combination induction therapy with guselkumab and golimumab, followed by a transition to guselkumab alone for maintenance, achieved a clinical remission ratea (based on the modified Mayo score [mMayo])b at week 38 of 47.9 percent, a higher rate than induction and maintenance treatment with either guselkumab alone (31.0 percent) or golimumab al...
Source: Johnson and Johnson - October 10, 2022 Category: Pharmaceuticals Source Type: news

Drug Shows Promise Against Autoimmune Disease Scleroderma
MONDAY, Oct. 10, 2022 -- Researchers report early success with using an existing rheumatoid arthritis (RA) drug to treat systemic sclerosis, a rare but potentially devastating autoimmune condition. The disease, a subset of scleroderma, hardens the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 10, 2022 Category: General Medicine Source Type: news

Tofacitinib Shows Promise Against Autoimmune Disease Scleroderma
MONDAY, Oct. 10, 2022 -- Researchers report early success with using an existing rheumatoid arthritis (RA) drug to treat systemic sclerosis, a rare but potentially devastating autoimmune condition. The disease, a subset of scleroderma, hardens the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 10, 2022 Category: General Medicine Source Type: news

Arthritis: Nine foods to reduce your risk of joint problems - high in vitamin C
Eating foods packed full of vitamin C could help lower your risk of arthritis and joint problems. (Source: Daily Express - Health)
Source: Daily Express - Health - October 9, 2022 Category: Consumer Health News Source Type: news

No Special Heart Risk With JAK Inhibitors, Study Finds
(MedPage Today) -- Patients taking Janus kinase (JAK) inhibitors for rheumatoid arthritis experienced similar cardiovascular outcomes as those using the tumor necrosis factor (TNF) blocker adalimumab (Humira), analysis of French national registry... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - October 7, 2022 Category: Cardiology Source Type: news